.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Examining Evolving Treatment Paradigms in the Hemophilia B Space

This content is a production of Managed Healthcare Executive; distribution of this K-Cast is supported by funding from CSL Behring LLC. CSL Behring LLC was not involved in the creation of the content of this production.

Steven Pipe, MD, discusses the treatment options for patients with hemophilia B, including his hope for future management of the bleeding joint disease.

Examining Evolving Treatment Paradigms in the Hemophilia B Space

EP. 1: An Overview of Hemophilia B

EP. 2: The Economic Burden of Hemophilia B From a Payer Perspective

EP. 3: Defining the Impact of Gene Therapy

EP. 4: Managing Hemophilia B Using Gene Therapy

EP. 5: Predicting the Treatment Evolution of Hemophilia B